Northern Trust Corp Cerus Corp Transaction History

Northern Trust Corp

  • $572 Billion
  • Q1 2024

A detailed history of Northern Trust Corp transactions in Cerus Corp stock. As of the latest transaction made, Northern Trust Corp holds 1,619,685 shares of CERS stock, worth $2.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,619,685
Previous 1,636,662 1.04%
Holding current value
$2.9 Million
Previous $3.54 Million 13.41%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$1.66 - $2.42 $28,181 - $41,084
-16,977 Reduced 1.04%
1,619,685 $3.06 Million
Q4 2023

Feb 13, 2024
SELL
$1.25 - $2.35 $260,018 - $488,835
-208,015 Reduced 11.28%
1,636,662 $3.54 Million
Q3 2023

Nov 13, 2023
SELL
$1.5 - $3.07 $16,564 - $33,902
-11,043 Reduced 0.6%
1,844,677 $2.99 Million
Q2 2023

Aug 11, 2023
BUY
$1.79 - $2.9 $60,750 - $98,423
33,939 Added 1.86%
1,855,720 $4.57 Million
Q1 2023

May 15, 2023
BUY
$2.65 - $3.81 $32,759 - $47,099
12,362 Added 0.68%
1,821,781 $5.41 Million
Q4 2022

Feb 13, 2023
BUY
$3.38 - $4.22 $111,580 - $139,310
33,012 Added 1.86%
1,809,419 $6.6 Million
Q3 2022

Nov 14, 2022
SELL
$3.43 - $5.83 $49,957 - $84,913
-14,565 Reduced 0.81%
1,776,407 $6.4 Million
Q2 2022

Aug 12, 2022
SELL
$4.41 - $5.69 $160,920 - $207,628
-36,490 Reduced 2.0%
1,790,972 $9.47 Million
Q1 2022

May 13, 2022
SELL
$4.81 - $6.99 $358,277 - $520,657
-74,486 Reduced 3.92%
1,827,462 $10 Million
Q4 2021

Feb 08, 2022
SELL
$5.97 - $7.93 $318,505 - $423,073
-53,351 Reduced 2.73%
1,901,948 $13 Million
Q3 2021

Nov 15, 2021
BUY
$4.79 - $6.68 $120,257 - $167,708
25,106 Added 1.3%
1,955,299 $11.9 Million
Q2 2021

Aug 13, 2021
SELL
$5.35 - $6.35 $94,143 - $111,740
-17,597 Reduced 0.9%
1,930,193 $11.4 Million
Q1 2021

May 12, 2021
SELL
$5.68 - $7.87 $889,686 - $1.23 Million
-156,635 Reduced 7.44%
1,947,790 $11.7 Million
Q4 2020

Feb 11, 2021
SELL
$5.25 - $8.56 $379,606 - $618,939
-72,306 Reduced 3.32%
2,104,425 $14.6 Million
Q3 2020

Nov 16, 2020
SELL
$5.78 - $7.47 $522,870 - $675,751
-90,462 Reduced 3.99%
2,176,731 $13.6 Million
Q2 2020

Aug 14, 2020
BUY
$4.5 - $7.02 $1.34 Million - $2.1 Million
298,601 Added 15.17%
2,267,193 $15 Million
Q1 2020

May 14, 2020
BUY
$2.87 - $5.49 $593,797 - $1.14 Million
206,898 Added 11.74%
1,968,592 $9.15 Million
Q4 2019

Feb 14, 2020
SELL
$3.84 - $4.86 $129,354 - $163,713
-33,686 Reduced 1.88%
1,761,694 $7.43 Million
Q3 2019

Nov 13, 2019
BUY
$4.86 - $6.05 $430,659 - $536,108
88,613 Added 5.19%
1,795,380 $9.25 Million
Q2 2019

Aug 13, 2019
BUY
$4.51 - $6.6 $190,407 - $278,645
42,219 Added 2.54%
1,706,767 $9.59 Million
Q1 2019

May 13, 2019
BUY
$5.16 - $6.85 $179,310 - $238,037
34,750 Added 2.13%
1,664,548 $10.4 Million
Q4 2018

Feb 12, 2019
SELL
$4.89 - $7.16 $72,929 - $106,784
-14,914 Reduced 0.91%
1,629,798 $8.26 Million
Q3 2018

Nov 14, 2018
BUY
$6.89 - $7.78 $603,026 - $680,921
87,522 Added 5.62%
1,644,712 $11.9 Million
Q2 2018

Sep 18, 2018
SELL
$5.19 - $7.25 $42,106 - $58,819
-8,113 Reduced 0.52%
1,557,190 $10.4 Million
Q2 2018

Aug 14, 2018
BUY
$5.19 - $7.25 $532,701 - $744,140
102,640 Added 7.02%
1,565,303 $10.4 Million
Q1 2018

May 09, 2018
BUY
$3.56 - $5.74 $491,956 - $793,210
138,190 Added 10.43%
1,462,663 $8.02 Million
Q4 2017

Feb 14, 2018
BUY
$2.76 - $3.95 $136,382 - $195,185
49,414 Added 3.88%
1,324,473 $4.48 Million
Q3 2017

Nov 13, 2017
BUY
$2.22 - $2.73 $2.83 Million - $3.48 Million
1,275,059
1,275,059 $3.48 Million

Others Institutions Holding CERS

# of Institutions
153
Shares Held
144M
Call Options Held
39.6K
Put Options Held
60.9K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email